Why the study?
Does non-invasive measurement of arterial blood pressure using Finapres provide comparable estimates of cardiac baroreflex sensitivity to direct aortic measurement in patients with coronary artery disease?
Does non-invasive measurement of arterial blood pressure using Finapres provide comparable estimates of cardiac baroreflex sensitivity to direct aortic measurement in patients with coronary artery disease?
Spectral analysis of cardiac baroreflex sensitivity provides better agreement between non-invasive Finapres and invasive aortic blood pressure measurements than sequence analysis.
Answers are grounded in this paper and cite their sources.
Finapres spectral BRS agrees with aortic measures in CAD; extends non-invasive validation but leaves sequence agreement open.
OBJECTIVE: To compare estimates of cardiac baroreceptor sensitivity (BRS) obtained by the Finapres device and from the direct measurement of arterial blood pressure (ABP) values from the ascending aorta, using both spectral analysis and sequence analysis. DESIGN: A cohort study of 45 coronary artery disease patients undergoing routine percutaneous coronary procedures. METHODS: Continuous supine recordings of resting ABP in the finger (Finapres), ascending aorta (Millar catheter-tip transducer) and electrocardiogram were obtained. Beat-to-beat values of systolic ABP (Finapres and aortic) and R-R interval were used to estimate the cardiac BRS from spontaneous sequences and by spectral analysis, using the alpha index for the low-frequency band (0.05-0.15 Hz). The influence of beta-blockers on BRS estimates was also investigated. RESULTS: No significant difference was observed between estimates of BRS derived from the Finapres (BRSFIN) and aortic ABP (BRSAO) by the spectral analysis method (Finapres bias 0.30 +/- 2.52 ms/mmHg). For sequence analysis, BRSFIN was significantly higher than BRSAO (7.80 +/- 4.52 versus 6.44 +/- 3.46 ms/mmHg), but the bias (1.36 +/- 3.10 ms/mmHg) was not significantly different from spectral analysis. No significant differences in BRS were found between beta-blocker users (n = 24) and non-users (n = 10) for either the processing method or source of ABP recording. CONCLUSION: Spectral analysis of cardiac BRS showed a better agreement between estimates obtained from the Finapres and aortic ABP.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: